Myogen

About:

Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics.

Website: http://www.myogen.com/

Top Investors: New Enterprise Associates, Adams Street Partners, InterWest Partners, Greenspring Associates, Silicon Valley Bank

Description:

Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders. They believe that our advanced understanding of the biology of cardiovascular disease combined with their clinical development expertise in cardiovascular therapeutics provide us with the capability to discover novel therapies, as well as identify, license or acquire products that address serious, debilitating cardiovascular disorders that are not adequately treated with existing therapies.

Total Funding Amount:

$188M

Headquarters Location:

Westminster, Colorado, United States

Founded Date:

1996-01-01

Founders:

Eric Newell Olson, Michael R. Bristow

Number of Employees:

51-100

Last Funding Date:

2003-08-29

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai